Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II)

Wiener Klinische Wochenschrift

Volumn 112, Issue 12, 2000, Pages 552-555

  Schneider, Thomas ^a   Heuer, Bettina ^a   Deller, Alois ^a   Boesken, Wolf Hermann ^a  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

Author keywords

Continuous veno venous haemofiltration; CVVH; Heparin induced thrombocytopenia; HIT II; R hirudin; Renal insufficiency

Indexed keywords

ANTIBODY; ANTICOAGULANT AGENT; HEPARIN; LEPIRUDIN;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CASE REPORT; CREATININE CLEARANCE; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PARTIAL THROMBOPLASTIN TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANEURYSM, DISSECTING; ANTICOAGULANTS; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; HEMODIAFILTRATION; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0034674305     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bucha E, Nowak G, Czerwinski R, Thieler H (1999) R-hirudin as anticoagulant in regular hemodialysis therapy: finding of therapeutic r-hirudin blood/plasma concentrations and respective dosages. Clin Appl Thrombosis/Hemostasis 5/3: 164-170
2. Eichler P, Greinacher A (1996) Anti-hirudin antibodies induced by recombinant hirudin in the treatment of heparininduced thrombocytopenia (HIT). Ann Hematol 72 [Suppl A4] (abstract)
3. Greinacher A, Zinn S, Wizeman V, Birk UW (1996) Heparin-induced antibodies as a risk factor for thromboembolism and hemorrhage in patients undergoing chronic haemodialysis. Lancet 348: 764
4. Huhle G, Hoffmann U, Song X, Wang LC, Heene DL, Harenberg J (1999) Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment. Br J Haematol 106: 195-201
5. Nowak G, Bucha E (1996) Quantitative determination of hirudin in blood and body fluids. Sem Thromb 22: 197-202
6. Nowak G, Bucha E, Brauns I, Czerwinski R (1997) Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). Wien Klin Wochenschr 109: 354-358
7. Nowak G (1999) Personal communication
8. Ranze O, Greinacher A (1999) Aktuelle Behandlungskonzepte bei Heparin-induzierter Thrombozytopenie. Dtsch Med Wochenschr 124: 865-873
9. Roe SD, Cassidy MJD, Haynes AP, Byrne JL (1998) Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis. Nephrol Dial Transplant 13: 3226-3229
10. Steuer S, Boogen C, Plum J, Deppe C, Reinauer H, Grabensee B (1999) Anticoagulation with r-hirudin in a patient with acute renal failure and heparin-induced thrombocytopenia. Nephrol Dial Transplant 14 [Suppl 4]: 45-47
11. Thieler H, Goeoeck Th, Nowak G (1991) 1st Hirudin als Antikoagulans bei dialysepflichtigen Patienten geeignet? Nieren- und Hochdruckkrankheiten 20: 453
12. Tholl U, Greinacher A, Overdick K, Anlauf M (1997) Life-threatening anaphylactic reaction following parathyroidectomy in a dialysis patient with heparin-induced thrombocytopenia. Nephrol Dial Transplant 12: 2750-2755
13. Vanholder R, Camez A, Veys N, Van Loo A, Dhondt AM, Ringoir S (1997) Pharmacokinetics of recombinant hirudin in haemodialyzed end-stage renal failure patients. Thrombosis and Haemostasis 77/4: 650-655
14. Wandel E, Klingel R, Köhler H (1992) Antikoagulation bei chronischer Dialyse. Arzneimitteltherapie 10: 310-313